Dabipla 75mg Capsule
Prescription Required
Product introduction
Dabipla 75mg Capsule is an anticoagulant or blood thinner. It helps prevent and treat blood clots. It is used to reduce the risk of stroke and heart attack. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart.
Dabipla 75mg Capsule is a medicine which makes your blood flow more easily. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart. It is used in patients with irregular heart rhythm (atrial fibrillation). It reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. Side effect of this medicine is that you can bleed too easily. Hence, it is advisable to use it with utmost care in conditions involving increased risk of bleeding. Unlike other anti-coagulants, regular blood test (PT-INR) is not required while taking this medicine.
Dabipla 75mg Capsule is a medicine which makes your blood flow more easily. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart. It is used in patients with irregular heart rhythm (atrial fibrillation). It reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. Side effect of this medicine is that you can bleed too easily. Hence, it is advisable to use it with utmost care in conditions involving increased risk of bleeding. Unlike other anti-coagulants, regular blood test (PT-INR) is not required while taking this medicine.
Uses of Dabipla Capsule
- Treatment and prevention of Blood clots
Benefits of Dabipla Capsule
In Treatment and prevention of Blood clots
Dabipla 75mg Capsule is a type of medicine known as an anticoagulant. Although it does not “dissolve” blood clots, it can prevent them from getting bigger so your body can dissolve them over time. It will also prevent new ones from forming. It works by blocking a substance in the body which is involved in blood clotting. This keeps your blood flowing freely around your body and makes it less likely that a clot will form inside a blood vessel. This can help prevent or reduce damage caused by stroke, clots in your lungs (pulmonary embolism), or other blood vessels (thrombosis). It can also make it less likely that parts of a clot will break off and travel to other parts of the body. You should take it regularly and make appropriate lifestyle changes to help this medicine be effective.
Side effects of Dabipla Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Dabipla
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabipla Capsule
Take this medicine in the dose and duration as advised by your doctor. Dabipla 75mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Dabipla 75mg Capsule.
Pregnancy
CONSULT YOUR DOCTOR
Dabipla 75mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Dabipla 75mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Dabipla 75mg Capsule does not usually affect your ability to drive.
Kidney
CAUTION
Dabipla 75mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Dabipla 75mg Capsule may be needed. Please consult your doctor.
Use of Dabipla 75mg Capsule is not recommended in patients with severe kidney disease.
Use of Dabipla 75mg Capsule is not recommended in patients with severe kidney disease.
Liver
CAUTION
Dabipla 75mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Dabipla 75mg Capsule may be needed. Please consult your doctor.
What if you forget to take Dabipla Capsule?
If you missed a dose of Dabipla 75mg Capsule, take it as soon as possible on the same day. The missed dose should be skipped if it cannot be taken at least 6 hours before the next scheduled dose. Do not double the dose to make up for a missed dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Dabipla 75mg Capsule
₹20.0/Capsule
Pradaxa 75mg Capsule
Boehringer Ingelheim
₹71.8/capsule
259% costlier
Afogatran 75mg Capsule
Torrent Pharmaceuticals Ltd
₹26.53/capsule
33% costlier
Dabiclot 75mg Capsule
Alkem Laboratories Ltd
₹24.2/capsule
21% costlier
Dabigat 75 Capsule
Natco Pharma Ltd
₹27.8/capsule
39% costlier
Dablexa 75 Capsule
Abbott L
₹33/capsule
65% costlier
Quick tips
- Take it as per dose and duration suggested by your doctor.
- Dabipla 75mg Capsule increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g., football and wrestling).
- If you are going to have a surgery or dental treatment, you may be asked to stop taking Dabipla 75mg Capsule temporarily.
- Your doctor may get a blood test done to check kidney function before starting treatment with this medicine.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
- Do not stop taking the medication without talking to your doctor.
Fact Box
Chemical Class
Benzimidazole derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Direct thrombin inhibitor- oral
Patient concerns
User feedback
Patients taking Dabipla 75mg Capsule
Twice A Day
100%
FAQs
When should I take Dabipla 75mg Capsule?
Mostly, Dabipla 75mg Capsule is suggested to be taken twice daily at the same time each day. The two doses should be taken at a gap of about 12 hours.
Can I drink alcohol with Dabipla 75mg Capsule?
Taking alcohol while taking Dabipla 75mg Capsule can increase the effect of this medicine, thereby increasing the chance of bleeding. Regular intake of alcohol can lead to a gastric ulcer which might again cause bleeding. So, it is better to avoid alcohol while you are taking this medicine. Do consult your doctor if any such episode of bleeding occurs.
Can Dabipla 75mg Capsule cause hair loss?
As compared to other blood-thinning medications, Dabipla 75mg Capsule does not usually cause hair loss. However, there do exist some rare reports of hair loss associated with Dabipla 75mg Capsule. Consult your doctor if you face hair loss while taking Dabipla 75mg Capsule to rule out any other causes of hair loss.
When will I feel better after taking Dabipla 75mg Capsule?
Dabipla 75mg Capsule reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Dabipla 75mg Capsule. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
Does Dabipla 75mg Capsule affect the liver?
Unlike other anticoagulants, Dabipla 75mg Capsule usually does not affect the functioning of the liver. But long-term use of Dabipla 75mg Capsule may increase the chances of mild liver injury in patients with elevated liver enzymes. However, the overall chances of developing any such problem are lower than other anticoagulants. It is advised that you inform your doctor if you have a history of liver disease before starting this medicine.
How should I store Dabipla 75mg Capsule?
Dabipla 75mg Capsule should be stored at room temperature between 59°F to 86°F (15°C to 30°C). Store the medicine at a dry place and protect the capsules from moisture. Close the bottle tightly after use and keep it out of the reach of children. Once the bottle is opened, it should be used within 4 months. If unused within 4 months, please discard them safely.
Can the use of Dabipla 75mg Capsule increase the risk of bleeding?
Yes, Dabipla 75mg Capsule increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
Who should not take Dabipla 75mg Capsule?
People experiencing any unusual bleeding or people allergic to Dabipla 75mg Capsule should not take it. Dabipla 75mg Capsule should also be avoided by people with artificial (prosthetic) heart valves. Therefore, inform your doctor if you have ever had or plan to have a valve in your heart replaced.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 865-66.
- Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 594.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 346-47.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 363-65.
- Dabigatran etexilate mesylate. Ridgefield, Connecticut: Boehringer Ingelheim Pharmaceuticals, Inc.; 2010 [revised Nov. 2015]. [Accessed 15 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Dabigatran. [Updated 2020 Jan 20]. [Accessed 19 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Dabigatran Etexilate. [Accessed 15 Mar. 2019] (online) Available from:
- Dabigatran Etexilate [Prescribing Information]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2021. [Accessed 16 Jun. 2023] (online) Available from:
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
46 people viewed this recentlyMRP
₹200
Inclusive of all taxes
10.0 capsules in 1 strip
SOLD OUT
Notify me